Programme

 

Atrial fibrillation – from atrial extrasystoles to atrial cardiomyopathy;
– What have we learned from basic science and interventional procedures?

A Scientific Meeting 16-17th April 2015, in Stockholm, Sweden

Time Title Chairs / Lecturers

Thursday April 16th

Carina Blomström Lundqvist
10.00 – 10.10 Welcome and introduction

10.15 – 12.15 Mechanisms of atrial fibrillation – from atrial triggers to atrial cardiomyopathy Ulrich Schotten
Pyotr Platonov
10.15 – 10.45 Molecular basis for triggers and perpetuators of atrial fibrillation Dobromir Dobrev
10.45 – 11.15 Longstanding persistent AF – a primary atrial cardiomyopathy state or the endstage of structural remodelling with atrial fibrosis ? Gerhard Hindriks
11.15 – 11.45 Specific fibrotic atrial cardiomyopathy – a challenge or the best substrate for AF ablation? Hans Kottkamp
11.45 – 12.15 Pulmonary vein triggers, focal firing, rotors – have they conquered the Multiple Wavelet Theory ? Ulrich Schotten
12.15 – 13.15 Lunch
13.15 – 15.15 Atrial Fibrillation – Epidemiology and Potential Targets for Prevention of AF John Camm
C Blomström Lundqvist
13.15 -13.45 Atrial fibrillation – an increase in prevalence and common cardiovascular riskfactors,
including sports?
John Camm
13.45 – 14.15 Lone atrial fibrillation – how ‘lone’ is it? Laurent Pison
14.15 – 14.45 Biomarkers  in atrial fibrillation: do they matter? Tatjana Potpara
14.45 – 15.15 Atrial cardiomyopathy and fibrosis – implications for drugs and catheter ablation. Gerhard Hindriks
15.15 – 15.45 Coffee break
What have we learned from ablation procedures of atrial fibrillation Karl-Heinz Kuck
David Mörtsell
15.45 – 16.15 Which endpoints for Pulmonary vein isolation? Louis Mont
16.15 – 16.45 Pulmonary vein isolation – standard procedure for all types of AF? C Blomström Lundqvist
16.45 – 17.15 Pulmonary vein isolation – new tools and techniques for more durable lesions? Gian-Battista Chierchia
17.10 – 17.30 Atrial Substrate Modification After Pulmonary Vein Isolation – a must in persistent AF or too high risk for gap related atrial tachycardias? Karl-Heinz Kuck
18.30 Faculty dinner – Läkaresällskapet

Friday April 17th

08.15 – 10.30 Pulmonary vein triggers, focal sources, rotors, and atrial cardiomyopathy – implications for choice of most effective therapy Michel Haissaguerre
José Jalife
08.15 – 08.45 Translation from basic science to the clinic: Mechanisms and Dynamics of Rotors in Atrial Fibrillation José Jalife
08.45 – 09.15 Focal Impulse and Rotor Modulation (FIRM) in Atrial Fibrillation Karl-Heinz Kuck
09.15 – 09.45 Body surface ECG mapping and cardiac imaging – Noninvasive and Invasive detection of rotors by definition, mechanism and prediction of cure ? Michel Haissaguerre
09.45 – 10.15 Thoracoscopic epicardial and endocardial atrial fibrillation ablation – a last but effective resource?? Laurent Pison
10.15 – 10.30 Break – activity + soft drink
10.30 – 12.30 Tailored treatment strategies – a new approach for modern AF management
Rhythm, rate and thromboembolic control
Isabelle C. Van Gelder
Jonas Schwieler
10.30 – 11.00 Antiarrhythmic Drug choice – tailored to genotype for prevention and cardioversion? Ulrich Schotten
11.00 – 11.30 Atrial stunning – implications for mode of cardioversion and anticoagulation therapy? Isabelle C. Van Gelder
11.30 – 12.00 The role of NOAC for cardioversions beyond the 48 hour time limit ? Riccardo Cappato
12.00 – 12.30 AF and chronic kidney disease – a bad combination Giuseppe Boriani
12.30 – 13.00 Left Atrial Appendage devices for Preventing Stroke – when to use and when not to? Thorsten Lewalter
13.00 – 14.00 Lunch
14.00 – 16.00 Tailored treatment strategy – a new approach for modern AF management?
Stroke prevention
GYH Lip
Leif Friberg
14.00 – 14.30 Rational for opportunistic screening for AF – when to proceed with anticoagulation therapy? Mårten Rosenqvist
14.30 – 15.00 Improved efficacy and safety of anticoagulation if tailored to patient’s profile? The role of genes and biomarkers GYH Lip
15.00 – 15.30 Optimal Periprocedural use of anticoagulation therapy – ablation, cardioversion and device surgery ? Giuseppe Boriani
15.30 – 16.00 The Patient with Acute Coronary Syndrome – the rational for individual anticogulation therapy and stent preference GYH Lip
16.00 End of session – Closing remarks